What we do
NeoClone produces high-quality monoclonal antibody products for the biotechnology and research markets. NeoClone holds exclusive license to the ABL-MYC retroviral transformation system, a technique that produces monoclonal antibodies -- "NeoClone^®"-brand or "NeoAb^®" antibodies -- in an accelerated time and with cost savings. NeoClone provides customers NeoAb antibodies faster and cheaper than monoclonal antibody companies using traditional methods.

Why we're good
faster, cheaper -- our ABL-MYC retroviral transformation system, cuts production time by an average of two months
better -- our system is more successful with problematic peptides
custom -- we can produce NeoAb antibodies to meet researchers' specific needs.
catalog -- we have a complete line of monoclonal antibodies to prokaryotic and eukaryotic transcription machinery

Company facts
NeoClone was founded in 1999 by University of Wisconsin colleagues and a few business types. Our office address is: 1202 Ann Street, Madison, WI 53713.

NeoClone is happy to supply potential customers, partners, and friends with lists of the people who make NeoClone possible and our repeat customers. Please contact us for more information.